Neurona Therapeutics
Latest round
- Series F
Last raised
- Mar 2025
Total raised
- $284M
Investors
- 19
About Neurona Therapeutics
Based in California, US, and founded in 2008 by co-founder and CEO Cory R. Nicholas, Neurona Therapeutics, Inc. is a clinical-stage biotherapeutics company that focuses on the development of cell-based therapeutics and treatment devices for neurological diseases and disorders. In April 2025, Neurona Therapeutics Inc. The company specializes in developing neural cell therapies for chronic neurological disorders. The company’s primary product, NRTX-1001, consists of inhibitory GABAergic interneurons derived from pluripotent stem cells. NRTX-1001 is also being studied for its potential benefits in Alzheimer's disease by repairing neural activity and improving cognition. This therapy addresses drug-resistant focal epilepsy by enhancing GABAergic inhibition to reduce seizure activity.
Who invested in Neurona Therapeutics
19 investors across 4 rounds
See all investors in Neurona Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neurona Therapeutics
Who invested in Neurona Therapeutics?
Neurona Therapeutics has 19 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neurona Therapeutics raised?
Neurona Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Neurona Therapeutics last raise money?
Neurona Therapeutics's most recent round on record is a Series F, in Mar 2025.
What does Neurona Therapeutics do?
Based in California, US, and founded in 2008 by co-founder and CEO Cory R.
Where is Neurona Therapeutics headquartered?
Neurona Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Neurona Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Neurona Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series F
Raising like Neurona Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.